Propofol注射液市场按产品类型、应用、剂型、最终用户、通路和地区划分

预计到 2025 年，Propofol注射剂市场价值将达到 16.2 亿美元，预计到 2032 年将达到 30.2 亿美元，2025 年至 2032 年的复合年增长率为 9.3%。

全球Propofol注射液市场是製药业的重要组成部分，涵盖了现代医学中最广泛使用的静脉麻醉剂之一。Propofol（化学名称：2,6-二异丙基苯酚）是一种短效镇静催眠药，主要用于全身麻醉的诱导和维持，以及加护病房和手术中的镇静。此註射液起效迅速、镇静深度可控制、恢復快、残留效应小，彻底改变了全球麻醉护理。

该市场涵盖各种浓度和配方的Propofol注射液，用于包括手术、诊断程序和加护治疗在内的各种医疗应用。医院、门诊手术中心和专科诊所等医疗机构是主要的终端用户，推动了市场需求。手术量的增加、需要医疗干预的老年人口增长以及门诊手术设施的扩张，都显着促进了市场扩张。此外，新兴市场对Propofol的日益普及，以及为改进配方而持续进行的研发工作，使该市场成为全球麻醉剂产业的重要组成部分。

市场动态

全球Propofol注射液市场受多种强烈因素驱动。其中最重要的因素是全球外科手术数量的快速增长，这源于人口老化对各种医疗干预（从常规手术到复杂手术）的需求。慢性疾病需要手术治疗的增加，以及新兴经济体医疗成本的上升和医疗基础设施的改善，都显着地推动了市场需求。此外，与传统麻醉剂相比，Propofol具有更优的药物动力学特性，例如起效更快、恢復更快、副作用更少、患者耐受性更好，这些特性也促使其在医疗机构中广泛应用。然而，该市场也面临一些显着的限制因素。主要限制因素在于麻醉剂严格的监管要求，这通常会导致漫长的核准流程和製造商高昂的合规成本。

Propofol滥用和非法分销的潜在风险已因一些备受瞩目的案例而凸显，导致多个司法管辖区加强了监管，并将其列为管制药物，从而增加了市场准入门槛。此外，由于需要特殊的储存条件和熟练的给药方式，丙泊酚在资源匮乏地区的使用受到限制。儘管存在这些挑战，但不断扩大的门诊手术市场带来了巨大的机会，Propofol快速恢復的特性在该市场尤为有利。开发新型製剂，包括无脂製剂和稳定性增强製剂，蕴藏着盈利的成长潜力。此外，开发中国家医疗意识的提高、医疗旅游的蓬勃发展以及微创手术的日益普及，也为全球Propofol注射剂生产商和经销商创造了巨大的市场机会。

本次调查的主要特点

• 本报告对全球Propofol注射市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和復合年增长率。
• 我们将重点介绍各个细分市场的潜在商机，并说明该市场具有吸引力的投资提案矩阵。
• 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业。
• 本报告根据以下参数对全球Propofol注射市场的主要参与企业进行了分析：公司概况、产品系列、主要亮点、财务表现和策略。
• 本报告的研究结果将使负责人和企业经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 这份全球Propofol注射市场报告的目标受众是该行业的各种相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
• 相关人员可以透过全球Propofol注射液市场分析中使用的各种策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

• 调查目的
• 先决条件
• 简称

第二章 市场范围

• 报告概述
  • 市场定义和范围
• 执行摘要

第三章：市场动态、监管与趋势分析

• 市场动态
• 司机
• 抑制因素
• 机会
• 影响分析
• 法规环境
• 产品上市及核准
• PEST分析
• 波特分析
• 併购趋势
• 产业趋势

4. 2020-2032年全球Propofol注射剂市场（依产品类型划分）

• 非专利的
• 品牌

5. 2020-2032年全球Propofol注射剂市场（依应用领域划分）

• 短期镇静（程序性镇静）
• 长期镇静（加护病房- ICU）
• 麻醉的诱导和维持

6. 2020-2032年全球Propofol注射剂市场（以剂型划分）

• 单剂量管瓶
• 多剂量管瓶
• 预填充式注射器

7. 2020-2032年全球Propofol注射液市场（依最终用户划分）

• 医院
• 门诊手术中心（ASC）
• 诊所
• 其他（例如，復健中心）

8. 2020-2032年全球Propofol注射剂市场（依通路划分）

• 医院药房
• 零售药房
• 网路药房

9. 2020-2032年全球Propofol注射剂市场（按地区划分）

• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲国家
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太其他地区
• 中东
  • GCC
  • 以色列
  • 其他中东国家
• 非洲
  • 南非
  • 北非
  • 中非

第十章 竞争格局

• Fresenius Kabi
• Baxter International
• Braun Melsungen AG
• AbbVie Inc.
• Pfizer Inc.
• Hikma Pharmaceuticals
• Teva Pharmaceutical Industries Ltd.
• 山德士（诺华旗下公司）
• Reddy's Laboratories
• Guangdong Jiabo Pharmaceutical
• Xian Libang Pharmaceutical
• Jiangsu Nhwa Pharmaceutical
• Sinopharm Guorui Pharmaceutical
• Midas Pharma
• Emcure Pharmaceuticals

第十一章 分析师建议

• 机会
• 一致的机会地图

第十二章 参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Propofol Injection Market is estimated to be valued at USD 1.62 Bn in 2025 and is expected to reach USD 3.02 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.

The global propofol injection market represents a critical segment within the pharmaceutical industry, encompassing one of the most widely utilized intravenous anesthetic agents in modern medical practice. Propofol, chemically known as 2,6-diisopropylphenol, serves as a short-acting sedative-hypnotic agent primarily employed for induction and maintenance of general anesthesia, as well as sedation in intensive care units and procedural settings. This injectable formulation has revolutionized anesthetic practices globally due to its rapid onset, controllable depth of sedation, and swift recovery profile with minimal residual effects.

The market encompasses various concentrations and formulations of propofol injections, catering to diverse medical applications including surgical procedures, diagnostic interventions, and critical care management. Healthcare institutions, including hospitals, ambulatory surgical centers, and specialty clinics, constitute the primary end-users driving market demand. The increasing prevalence of surgical procedures, growing geriatric population requiring medical interventions, and expanding outpatient surgical facilities significantly contribute to market expansion. Additionally, the rising adoption of propofol in emerging markets, coupled with continuous research and development initiatives for improved formulations, positions this market as a vital component of the global anesthesia pharmaceutical landscape.

Market Dynamics

The global propofol injection market is propelled by several compelling drivers, with the foremost being the exponential increase in surgical procedures worldwide, driven by an aging population requiring various medical interventions, from routine surgeries to complex operations. The growing prevalence of chronic diseases necessitating surgical treatments, coupled with rising healthcare expenditure and improved healthcare infrastructure in emerging economies, significantly boosts the market demand. Additionally, the preference for propofol over traditional anesthetic agents due to its superior pharmacokinetic properties, including rapid onset and recovery, minimal side effects, and excellent patient tolerance, drives adoption across healthcare facilities. However, the market faces notable restraints, primarily centered around stringent regulatory requirements for anesthetic drugs, which often result in lengthy approval processes and substantial compliance costs for manufacturers.

The potential for abuse and diversion of propofol, highlighted by high-profile cases, has led to increased regulatory scrutiny and controlled substance scheduling in various jurisdictions, creating additional barriers for market accessibility. Furthermore, the requirement for specialized storage conditions and skilled administration limits its usage in resource-constrained settings. Despite these challenges, significant opportunities emerge from the expanding outpatient surgical procedures market, where propofol's rapid recovery profile is particularly advantageous. The development of novel formulations, including lipid-free alternatives and enhanced stability versions, presents lucrative growth prospects. Additionally, increasing healthcare awareness in developing nations, expanding medical tourism, and the growing trend toward minimally invasive procedures create substantial market opportunities for propofol injection manufacturers and distributors globally.

Key Features of the Study

• This report provides in-depth analysis of the global propofol injection market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global propofol injection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include leading Fresenius Kabi, Baxter International, B. Braun Melsungen AG, AbbVie Inc., Pfizer Inc., Hikma Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Sandoz (a Novartis division), Dr. Reddy's Laboratories, Guangdong Jiabo Pharmaceutical, Xian Libang Pharmaceutical, Jiangsu Nhwa Pharmaceutical, Sinopharm Guorui Pharmaceutical, Midas Pharma, and Emcure Pharmaceuticals
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global propofol injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global propofol injection market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Generic
  • Branded
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Short-term Sedation (Procedural Sedation)
  • Endoscopy (Colonoscopy, Upper GI Endoscopy)
  • Bronchoscopy
  • Cardioversion
  • Minor Surgical Procedures
  • Long-term Sedation (Intensive Care Unit - ICU)
  • Induction and Maintenance of Anesthesia
• Formulation Insights (Revenue, USD Bn, 2020 - 2032)
  • Single-Dose Vials
  • Multi-Dose Vials
  • Pre-filled Syringes
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Clinics
  • Others (e.g., Recovery Centers)
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Fresenius Kabi
  • Baxter International
  • Braun Melsungen AG
  • AbbVie Inc.
  • Pfizer Inc.
  • Hikma Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz (a Novartis division)
  • Reddy's Laboratories
  • Guangdong Jiabo Pharmaceutical
  • Xian Libang Pharmaceutical
  • Jiangsu Nhwa Pharmaceutical
  • Sinopharm Guorui Pharmaceutical
  • Midas Pharma
  • Emcure Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Propofol Injection Market, By Product Type
  • Global Propofol Injection Market, By Application
  • Global Propofol Injection Market, By Formulation
  • Global Propofol Injection Market, By End User
  • Global Propofol Injection Market, By Distribution Channel
  • Global Propofol Injection Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Propofol Injection Market, By Product Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Generic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Branded
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Propofol Injection Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Short-term Sedation (Procedural Sedation)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Endoscopy (Colonoscopy, Upper GI Endoscopy)
    • Bronchoscopy
    • Cardioversion
    • Minor Surgical Procedures
• Long-term Sedation (Intensive Care Unit - ICU)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Induction and Maintenance of Anesthesia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Propofol Injection Market, By Formulation, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Single-Dose Vials
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Multi-Dose Vials
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pre-filled Syringes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Propofol Injection Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers (ASCs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (e.g., Recovery Centers)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Propofol Injection Market, By Distribution Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Propofol Injection Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Fresenius Kabi
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Baxter International
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Braun Melsungen AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AbbVie Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hikma Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sandoz (a Novartis division)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Reddy's Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Guangdong Jiabo Pharmaceutical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Xian Libang Pharmaceutical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Jiangsu Nhwa Pharmaceutical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sinopharm Guorui Pharmaceutical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Midas Pharma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Emcure Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us